| __timestamp | Bausch Health Companies Inc. | Jazz Pharmaceuticals plc |
|---|---|---|
| Wednesday, January 1, 2014 | 2254600000 | 117418000 |
| Thursday, January 1, 2015 | 2645000000 | 102526000 |
| Friday, January 1, 2016 | 2611000000 | 105386000 |
| Sunday, January 1, 2017 | 2548000000 | 110188000 |
| Monday, January 1, 2018 | 2351000000 | 121544000 |
| Tuesday, January 1, 2019 | 2350000000 | 127930000 |
| Wednesday, January 1, 2020 | 2249000000 | 148917000 |
| Friday, January 1, 2021 | 2394000000 | 440760000 |
| Saturday, January 1, 2022 | 2364000000 | 540517000 |
| Sunday, January 1, 2023 | 2559000000 | 435577000 |
Unlocking the unknown
In the competitive landscape of pharmaceuticals, cost efficiency is a critical metric. Over the past decade, Jazz Pharmaceuticals plc and Bausch Health Companies Inc. have demonstrated contrasting approaches to managing their cost of revenue. From 2014 to 2023, Bausch Health consistently maintained a higher cost of revenue, averaging around $2.4 billion annually. In contrast, Jazz Pharmaceuticals operated with a significantly leaner cost structure, averaging approximately $225 million per year.
Interestingly, Jazz Pharmaceuticals showed a remarkable increase in cost efficiency, with a 370% rise in cost of revenue from 2014 to 2022, peaking in 2022. Meanwhile, Bausch Health's cost of revenue remained relatively stable, with minor fluctuations, indicating a steady operational strategy. This comparison highlights the diverse strategies in cost management within the pharmaceutical industry, offering insights into how companies balance growth and efficiency.
Comparing Cost of Revenue Efficiency: Johnson & Johnson vs Jazz Pharmaceuticals plc
Comparing Cost of Revenue Efficiency: Vertex Pharmaceuticals Incorporated vs Jazz Pharmaceuticals plc
Cost of Revenue: Key Insights for Viatris Inc. and Jazz Pharmaceuticals plc
BioMarin Pharmaceutical Inc. vs Bausch Health Companies Inc.: Efficiency in Cost of Revenue Explored
Analyzing Cost of Revenue: Jazz Pharmaceuticals plc and Alkermes plc
Comparing Cost of Revenue Efficiency: Jazz Pharmaceuticals plc vs Cytokinetics, Incorporated
Cost of Revenue Comparison: Jazz Pharmaceuticals plc vs ACADIA Pharmaceuticals Inc.
Jazz Pharmaceuticals plc vs Agios Pharmaceuticals, Inc.: Efficiency in Cost of Revenue Explored
Comparing SG&A Expenses: Jazz Pharmaceuticals plc vs Bausch Health Companies Inc. Trends and Insights
Cost of Revenue Trends: Amneal Pharmaceuticals, Inc. vs Bausch Health Companies Inc.
Cost Insights: Breaking Down Bausch Health Companies Inc. and Vericel Corporation's Expenses
Comparing Cost of Revenue Efficiency: Bausch Health Companies Inc. vs Mesoblast Limited